QLUCORE AB

In precision medicine, the real bottleneck is not the collection of biological data — now abundant thanks to genomic sequencing and omics technologies — but the ability to interpret that data quickly, interactively, and meaningfully. Qlucore was built to address this challenge, offering bioinformatics and data visualization software that lets researchers and clinicians explore complex datasets without writing a single line of code. Qlucore's approach is visual and interactive: the platform allows users to manipulate genomic, transcriptomic, and multi-omics data in real time, surfacing patterns and correlations that would be difficult to detect with traditional statistical methods. This is particularly valuable in translational research contexts, where connecting molecular data to clinical outcomes can open the door to new diagnostic and therapeutic hypotheses. Qlucore's customers include academic and institutional researchers, bioinformatics teams at biotech and pharma companies, molecular pathologists, and clinical facilities analyzing diagnostic omics data. This is a broad and growing audience, driven by the expansion of sequencing technologies and the rise of personalized medicine as a standard of care for certain oncological and rare diseases. The business model is B2B, centered on a software platform. Ease of use is a key differentiator: many bioinformatics tools require advanced programming skills, while Qlucore is designed for scientists and clinicians without a computational background. Lowering this barrier substantially widens the addressable market, placing advanced analytical capabilities directly in the hands of those making clinical decisions.